Clinical Trial Update: Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating topical PAN-90806 for neovascular age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• PAN-90806

Snippet

Sponsor: PanOptica, Inc. | Conditions: Age-Related Macular Degeneration (AMD) | Phase 1 | Status: COMPLETED